Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Dalteparin Sodium Market Outlook 2016-2021

  • GEN713956
  • 106 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Dalteparin is a low molecular weight heparin. It is marketed as Fragmin by Pfizer Inc. Like other low molecular weight heparins, dalteparin is used for prophylaxis or treatment of deep vein thrombosis and pulmonary embolism. It is normally administered by self-injection.

The CLOT study, published in 2003, showed that in patients with malignancy and acute venous thromboembolism, dalteparin was more effective than warfarin in reducing the risk of recurrent embolic events. Dalteparin is not superior to unfractionated heparin in preventing blood clots.

Heparins are cleared by the kidneys, but studies have shown that dalteparin does not accumulate even if kidney function is reduced.

This report provides detailed analysis of worldwide markets for Dalteparin Sodium from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Dalteparin Sodium market and further lays out an analysis of the factors influencing the supply/demand for Dalteparin Sodium, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC’s report, Global Dalteparin Sodium Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Dalteparin Sodium market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Dalteparin Sodium market are Pfizer (USA), Reliable Biopharmaceutical (USA), Gland Pharma (India), Opocrin (Italy), Hebei Changshan (China), Changzhou Qianhong (China), Nanjing Kingfriend (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Dalteparin Sodium industry has been provided.

Table Of Contents

Part 1. Scope of Report

1.1 Methodology

1.2 Geographic Scope

1.3 Years Considered

Part 2. Introduction

2.1 Definition

2.2 Current Scenario

2.2 Future Scenario

Part.3 Value Chain Analysis

3.1 Upstream

3.2 Downstream

Part 4. Manufacture

4.1 Manufacturing Process

4.2 Issues and Trends

4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors

5.1 Company A

5.1.1 Business Overview

5.1.2 Products Offered

5.1.3 Business Performance

5.2 Company B

5.3 Company C

5.4 Company D

5.5 Company E

5.6 Company F

5.7 Company G

5.8 Company H

5.9 Company I

5.10 Company J

Part 6. Market Overview

6.1 Global Production Volume 2011-2016

6.2 Production Volume by Region 2011-2016

6.2.1 North America

6.2.2 EMEA

6.2.3 Asia-Pacific

6.2.4 ROW

6.3 Global Production Value 2011-2016

6.4 Production Value by Region

6.4.1 North America

6.4.2 EMEA

6.4.3 Asia-Pacific

6.4.4 ROW

Part 7. Consumption Pattern

7.1 Regional Consumption

7.1.1 North America

7.1.2 EMEA

7.1.3 Asia-Pacific

7.1.4 ROW

7.2 Global Consumption by Application

Part 8. Market Forecast

8.1 Market Size by Volume

8.1.1 North America

8.1.2 EMEA

8.1.3 Asia-Pacific

8.1.4 ROW

8.2 Market Size by Value

8.2.1 North America

8.2.2 EMEA

8.2.3 Asia-Pacific

8.2.4 ROW

8.3 Regional Consumption Forecast

8.3.1 North America

8.3.2 EMEA

8.3.3 Asia-Pacific

8.3.4 ROW

8.4 Consumption Forecast by Application

Part 9. Market Dynamics

9.1 Market Drivers

9.2 Market Constraints

9.3 Market Strategies

Part 10 Key Events

10.1 Mergers & Acquisitions

10.2 New Product Launches

10.3 Expansions

10.4 Other Developments



List Of Tables

Figure Global Dalteparin Sodium Production Volume (Unit) 2011-2016

Figure Global Dalteparin Sodium Production Value (M USD) 2011-2016

Figure Top 10 Dalteparin Sodium Vendors Production Volume Share 2015

Figure Top 10 Dalteparin Sodium Vendors Production Value Share 2015

Figure Regional Dalteparin Sodium Production (Unit) 2015

Figure Regional Dalteparin Sodium Production Value (M USD) 2015

Table Raw Material Materials Suppliers

Figure Global Dalteparin Sodium Consumption Pattern 2015

Figure Manufacturing Cost Structure

Figure Company A Dalteparin Sodium Products

Table Company A Financial Performance 2011-2016

Figure Company A Market Share 2011-2016

Figure Company B Dalteparin Sodium Products

Table Company B Financial Performance 2011-2016

Figure Company B Market Share 2011-2016

Figure Company C Dalteparin Sodium Products

Table Company C Financial Performance 2011-2016

Figure Company C Market Share 2011-2016

Figure Company D Dalteparin Sodium Products

Table Company D Financial Performance 2011-2016

Figure Company D Market Share 2011-2016

Figure Company E Dalteparin Sodium Products

Table Company E Financial Performance 2011-2016

Figure Company E Market Share 2011-2016

Figure Company F Dalteparin Sodium Products

Table Company F Financial Performance 2011-2016

Figure Company F Market Share 2011-2016

Figure Company G Dalteparin Sodium Products

Table Company G Financial Performance 2011-2016

Figure Company G Market Share 2011-2016

Figure Company H Dalteparin Sodium Products

Table Company H Financial Performance 2011-2016

Figure Company H Market Share 2011-2016

Figure Company I Dalteparin Sodium Products

Table Company I Financial Performance 2011-2016

Figure Company I Market Share 2011-2016

Figure Company J Dalteparin Sodium Products

Table Company J Financial Performance 2011-2016

Figure Company J Market Share 2011-2016

Table Global Key Dalteparin Sodium Vendors Production (Unit) 2011-2016

Table Global Key Dalteparin Sodium Vendors Production Share 2011-2016

Figure Global Dalteparin Sodium Capacity & Production (Unit), Capacity Utilization 2011-2016

Figure Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2011-2016

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2011

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2012

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2013

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2014

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2015

Table Global Top 10 Dalteparin Sodium Vendors Production (Unit) 2016

Figure Dalteparin Sodium Production Volume (Unit) 2011-2016

Table Global Production Volume (Unit) 2011-2016

Table Global Production Volume Share 2011-2016

Figure North America Dalteparin Sodium Capacity & Production (Unit)

Figure North America Production Share Trend

Figure EMEA Dalteparin Sodium Capacity & Production (Unit)

Figure EMEA Production Share Trend

Figure Asia-Pacific Dalteparin Sodium Capacity & Production (Unit)

Figure Asia-Pacific Production Share Trend

Figure ROW Dalteparin Sodium Capacity & Production (Unit)

Figure ROW Production Share Trend Change

Figure Global Dalteparin Sodium Production Value (M USD), Growth Rate

Table Global Key Dalteparin Sodium Vendors Production Value (M USD) 2011-2016

Table Global Key Dalteparin Sodium Vendors Production Value Share 2011-2016

Figure Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2011-2016

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2011

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2012

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2013

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2014

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2015

Table Global Top 10 Dalteparin Sodium Vendors Production Value (M USD) 2016

Figure Dalteparin Sodium Prices (USD/Ton) 2016

Figure Dalteparin Sodium Gross Margin 2016

Figure Dalteparin Sodium Production Value (M USD) By Region 2011-2016

Table Global Dalteparin Sodium Production Value (M USD) 2011-2016

Table Global Dalteparin Sodium Production Value Share 2011-2016

Figure North America Production Value (M USD), Growth Rate

Figure North America Dalteparin Sodium Production Value Share Trend

Figure EMEA Production Value (M USD), Growth Rate

Figure EMEA Dalteparin Sodium Production Value Share Trend

Figure Asia-Pacific Production Value (M USD), Growth Rate

Figure Asia-Pacific Dalteparin Sodium Production Value Share Trend

Figure ROW Production Value (M USD), Growth Rate

Figure ROW Dalteparin Sodium Production Value Share Trend

Figure Global Dalteparin Sodium Consumption Volume (Unit) 2015

Table Regional Dalteparin Sodium Consumption Volume (Unit) 2011-2016

Table Regional Dalteparin Sodium Consumption Volume Share 2011-2016

Figure Dalteparin Sodium Consumption in North America 2011-2016

Figure Dalteparin Sodium Consumption in EMEA 2011-2016

Figure Dalteparin Sodium Consumption in Asia-Pacific 2011-2016

Figure Dalteparin Sodium Consumption in ROW 2011-2016

Figure Global Dalteparin Sodium Consumption Volume (Unit) 2016

Table Global Dalteparin Sodium Consumption Volume (Unit) 2011-2016

Table Global Dalteparin Sodium Consumption Volume Share 2011-2016

Figure Global Dalteparin Sodium Production (Unit) Forecast 2016-2021

Table Global Dalteparin Sodium Production (Unit) 2016-2021

Table Global Dalteparin Sodium Production Share 2016-2021

Figure North Dalteparin Sodium Production (Unit) Forecast 2016-2021

Figure EMEA Dalteparin Sodium Production (Unit) Forecast 2016-2021

Figure Asia-Pacific Dalteparin Sodium Production (Unit) Forecast 2016-2021

Figure ROW Dalteparin Sodium Production (Unit) Forecast 2016-2021

Figure Global Dalteparin Sodium Revenue (M USD) Forecast 2016-2021

Table Global Dalteparin Sodium Revenue (M USD) 2016-2021

Table Global Dalteparin Sodium Revenue Share 2016-2021

Figure North America Dalteparin Sodium Revenue (M USD) Forecast 2016-2021

Figure EMEA Dalteparin Sodium Revenue (M USD) Forecast 2016-2021

Figure Asia-Pacific Dalteparin Sodium Revenue (M USD) Forecast 2016-2021

Figure ROW Dalteparin Sodium Revenue (M USD) Forecast 2016-2021

Figure Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021

Table Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021

Table Global Dalteparin Sodium Consumption Volume Share 2016-2021

Figure North America Dalteparin Sodium Consumption (Unit) Forecast

Figure EMEA Dalteparin Sodium Consumption (Unit) Forecast

Figure Asia-Pacific Dalteparin Sodium Consumption (Unit) Forecast

Figure ROW Dalteparin Sodium Consumption (Unit) Forecast

Figure Global Dalteparin Sodium Consumption Volume (Unit) 2021

Table Global Dalteparin Sodium Consumption Volume (Unit) 2016-2021

Table Global Dalteparin Sodium Consumption Volume Share 2016-2021

Table Key Strategies for Dalteparin Sodium Multinational Corporations

Table Key Strategies for Dalteparin Sodium Emerging-Market Players



List Of Figures

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370